Sign Out
Pregnancy: CERVIDIL is for the initiation of cervical ripening in pregnant patients at term (from 37 completed weeks) only where labour induction is indicated.
CERVIDIL is not indicated for use in pregnancy prior to 37 completed weeks of gestation.
Breast-feeding: No studies have been performed to investigate the amount of dinoprostone in colostrum or breast milk following the use of CERVIDIL.
Dinoprostone may be excreted in colostrum and breast milk, but the level and duration is expected to be very limited and should not hinder breastfeeding. No effects on the breastfed newborns have been observed in the clinical studies conducted.
Continue with Google